CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net revenues	$ 44,048,740	$ 32,989,742
Costs and expenses:
Cost of services	34,000,786	22,067,421
General and administrative	16,962,687	11,282,221
Depreciation and amortization	351,396	334,434
Total costs and expenses	51,314,869	33,684,076
Loss from operations	(7,266,129)	(694,334)
Other (expense) income:
Interest expense	(542,296)	(1,326,407)
(Loss) gain on change in fair value of warrant and conversion feature liabilities, net	(408,692)	833,545
Loss on debt extinguishment, net	(266,366)	0
Other income	239,057	3,031
Total other expense, net	(978,297)	(489,831)
Loss before (benefit) provision for income taxes	(8,244,426)	(1,184,165)
(Benefit) provision for income taxes	(71,037)	163,792
Net loss	(8,173,389)	(1,347,957)
Net income attributable to noncontrolling interests	1,170,655	454,644
Net loss attributable to Apollo Medical Holdings, Inc.	$ (9,344,044)	$ (1,802,601)
Net loss per share:
Basic and diluted (in dollars per share)	$ (1.79)	$ (0.37)
Weighted average shares of common stock outstanding:
Basic and diluted (in shares)	5,212,927	4,891,652